Back to results
US 2012/0071495 A1Published application
Treatment for Neurological and Mental Disorders
AssigneePsychogenics, Inc.
InventorsEmer Leahy, Mark Day
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
AssigneePsychogenics, Inc.
InventorsEmer Leahy, Mark Day
Estimating the term…
Methods for treating neurological or mental disorders in humans and the symptoms associated therewith are provided by administering eltoprazine and/or related compounds. In some embodiments, specific symptoms are treated by administering eltoprazine and/or a related compound in an effective amount to ameliorate the symptoms. Of particular significance are symptoms that are associated with cognitive dysfunction where eltoprazine will improve the symptoms and the disorder associated with that symptom. Of particular interest are non-ADHD-associated inattention, hyperactivity and impulsiveness. The methods provided herein are especially useful for improving functional recovery after CNS injury such as stroke where improved cognitive function will facilitate the acquisition of learning and memory of rehabilitative tasks.
A method of treating a neurological or mental disorder associated with cognitive impairment with one or more of hyperactivity, inattention or impulsivity other than ADHD comprising administering to an individual having symptoms of the neurological disease an effective amount of eltoprazine or a pharmaceutically acceptable acid addition salt thereof to improve the symptoms of the neurological or mental disorder.
A method of treating hyperactivity associated with a neurological or mental disorder other than ADHD comprising administering to an individual in need an effective amount of eltoprazine or a pharmaceutically acceptable acid addition salt thereof to improve or treat hyperactivity.
A method of treating inattention associated with a neurological or mental disorder other than ADHD comprising administering to an individual in need an effective amount of eltoprazine or a pharmaceutically acceptable acid addition salt thereof to improve or treat inattention.
A method of treating impulsivity associated with a neurological or mental disorder other than ADHD comprising administering to an individual in need an effective amount of eltoprazine or a pharmaceutically acceptable acid addition salt thereof to improve or treat impulsivity.
A method of improving cognitive function in humans comprising administering to an individual in need an effective amount eltoprazine or a pharmaceutically acceptable acid addition salt thereof to improve cognitive function.
A method of treating psychomotor retardation comprising administering to an individual diagnosed with psychomotor retardation an effective amount of eltoprazine or a pharmaceutically acceptable acid addition salt thereof.
A method of treating cognitive disinhibition comprising administering to an individual diagnosed with psychomotor retardation an effective amount of eltoprazine or a pharmaceutically acceptable acid addition salt thereof.
Dependencies are inferred from the claim text.